These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29794822)

  • 1. Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes.
    Chen S; Wang X; Zhu H; Tang Q; Du W; Cao H; Lai C; Guo W; Fu L; Lu W
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):126-134. PubMed ID: 29794822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
    J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro.
    Fjeldborg K; Møller HJ; Richelsen B; Pedersen SB
    J Mol Endocrinol; 2014 Oct; 53(2):227-35. PubMed ID: 25074267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
    BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD163 levels, pro- and anti-inflammatory cytokine secretion of monocytes in children with pulmonary tuberculosis.
    Aktas Cetin E; Pur Ozyigit L; Gelmez YM; Cakir E; Gedik AH; Deniz G
    Pediatr Pulmonol; 2017 May; 52(5):675-683. PubMed ID: 27685837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
    Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
    J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT
    Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.
    O'Connell GC; Tennant CS; Lucke-Wold N; Kabbani Y; Tarabishy AR; Chantler PD; Barr TL
    Sci Rep; 2017 Oct; 7(1):12940. PubMed ID: 29021532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
    Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
    J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
    Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C
    Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.
    Kjærgaard AG; Rødgaard-Hansen S; Dige A; Krog J; Møller HJ; Tønnesen E
    PLoS One; 2014; 9(3):e92331. PubMed ID: 24637679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection.
    Generoso M; Álvarez P; Kravietz A; Mwamzuka M; Marshed F; Ahmed A; Khaitan A
    AIDS; 2020 Jan; 34(1):33-38. PubMed ID: 31567161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
    Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H; Mizuno K; Okamoto H
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.